CME Group Inc. (CME) Valuation
Historical valuation analysis based on 1280 data points (2021-09-13 to 2026-10-16)
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies,...
CME Group Inc. (CME) currently trades at a P/E ratio of 24.51 (historical range: 18.48–37.08, median: 25.02), placing it at the 41th percentile — near its historical average, P/S ratio of 15.60 (range: 11.75–19.39, 78th percentile — above its historical average), EV/EBITDA of 24.33 (range: 18.19–34.73, 77th percentile).
CME Group Inc. trades above its historical valuation range, with most metrics above their median levels.
Historical Valuation Metrics
| Metric | Current | Median | %ile | Assessment |
|---|---|---|---|---|
| P/E Ratio | 24.51 | 25.02 | 41th | near its historical average |
| P/S Ratio | 15.60 | 14.48 | 78th | above its historical average |
| EV/EBITDA | 24.33 | 22.58 | 77th | above its historical average |
| FCF Yield | 3.99% | 4.17% | 33th | above its historical average |
CME Group Inc. (CME) Valuation & P/E History
CME Group Inc. (CME) is a US-listed stock operating in the Financial Services sector, specifically the Security & Commodity Brokers, Dealers, Exchanges & Services industry currently trading at $293.87 with a market capitalization of $105.7 billion. This page provides historical valuation analysis for CME based on 1280 data points covering 2021-09-13 to 2026-10-16. The P/E ratio of 24.51 is below the historical median of 25.02, placing CME at the 41th percentile of its valuation range. The P/S ratio of 15.60 compares to a median of 14.48.
CME Valuation Metrics & Historical Range
The valuation table above shows CME Group Inc.'s current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether CME is currently trading above or below its typical valuation levels.
- P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests CME is expensively valued; below the median suggests it is cheap.
- P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
- EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for CME Group Inc..
- FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.
Is CME Overvalued or Undervalued?
CME Group Inc. trades above its historical valuation range, with most metrics above their median levels. The overall valuation percentile of 65 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive CME is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.
However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full CME analysis page for a complete picture.
Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.CME trades on NYSE. This page is for informational purposes only and is not financial advice.